Latest Breaking News On - Allergan united states inc - Page 1 : comparemela.com

United States - Patent - In Re Cellect: What's The Issue And What To Expect

The Supreme Court is about to receive a Petition for Certiorari in a case that impacts how long a patent protects new inventions, we expect. Specifically, the case addresses the Patent Term.

In Re Cellect: What's The Issue and What to Expect | Foley Hoag LLP

What Congress has guaranteed, the courts have taken away - The Supreme Court is about to receive a Petition for Certiorari in a case that impacts how long a patent.

The Case Law on Obviousness-Type Double Patenting: How We Got Here and a Proposal for Change (Part II)

Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd. - Patent

In Acadia Pharms., Inc. v. Aurobindo Pharma Ltd., No. 20-985-GBW (D. Del. Dec. 2023), the district court granted Acadia's motion for summary judgment of no invalidity.

In Wake Of In Re Cellect, District Court Interprets Safe Harbor Statute And Finds Patent Not Invalid For Obviousness-Type Double Patenting - Patent

The requirement that the "divisional application is filed before the issuance of the patent…" is inapplicable when the challenged patent issues from the original application.